Works matching IS 03407004 AND DT 2019 AND VI 68 AND IP 1


Results: 15
    1
    2

    Addressing current challenges and future directions in immuno-oncology: expert perspectives from the 2017 NIBIT Foundation Think Tank, Siena, Italy.

    Published in:
    Cancer Immunology, Immunotherapy, 2019, v. 68, n. 1, p. 1, doi. 10.1007/s00262-018-2285-y
    By:
    • Maio, Michele;
    • Coukos, George;
    • Ferrone, Soldano;
    • Fox, Bernard A.;
    • Fridman, Wolf H.;
    • Garcia, Patrick L.;
    • Lahn, Michael;
    • Provendier, Olivier;
    • Russo, Vincenzo;
    • Rüttinger, Dominik;
    • Shalabi, Aiman;
    • Trajanoski, Zlatko;
    • Viallet, Jean;
    • Wolchok, Jedd D.;
    • Ibrahim, Ramy
    Publication type:
    Article
    3
    4
    5

    Soluble CTLA-4 as a favorable predictive biomarker in metastatic melanoma patients treated with ipilimumab: an Italian melanoma intergroup study.

    Published in:
    Cancer Immunology, Immunotherapy, 2019, v. 68, n. 1, p. 97, doi. 10.1007/s00262-018-2258-1
    By:
    • Pistillo, Maria Pia;
    • Fontana, Vincenzo;
    • Morabito, Anna;
    • Dozin, Beatrice;
    • Laurent, Stefania;
    • Carosio, Roberta;
    • Banelli, Barbara;
    • Ferrero, Francesca;
    • Spano, Laura;
    • Tanda, Enrica;
    • Ferrucci, Pier Francesco;
    • Martinoli, Chiara;
    • Cocorocchio, Emilia;
    • Guida, Michele;
    • Tommasi, Stefania;
    • De Galitiis, Federica;
    • Pagani, Elena;
    • Antonini Cappellini, Gian Carlo;
    • Marchetti, Paolo;
    • Quaglino, Pietro
    Publication type:
    Article
    6
    7

    Prediction of neoepitopes from murine sequencing data.

    Published in:
    Cancer Immunology, Immunotherapy, 2019, v. 68, n. 1, p. 159, doi. 10.1007/s00262-018-2254-5
    By:
    • Bjerregaard, Anne-Mette;
    • Pedersen, Thomas Kainamura;
    • Marquard, Andrea Marion;
    • Hadrup, Sine Reker
    Publication type:
    Article
    8

    Serum miRNA-based distinct clusters define three groups of breast cancer patients with different clinicopathological and immune characteristics.

    Published in:
    Cancer Immunology, Immunotherapy, 2019, v. 68, n. 1, p. 57, doi. 10.1007/s00262-018-2252-7
    By:
    • Fortis, Sotirios P.;
    • Vaxevanis, Christoforos K.;
    • Mahaira, Louisa G.;
    • Sofopoulos, Michael;
    • Sotiriadou, Nectaria N.;
    • Dinou, Amalia;
    • Arnogiannaki, Niki;
    • Stavropoulos-Giokas, Catherine;
    • Thanos, Dimitris;
    • Baxevanis, Constantin N.;
    • Perez, Sonia A.
    Publication type:
    Article
    9
    10
    11
    12
    13

    An autologous dendritic cell vaccine polarizes a Th-1 response which is tumoricidal to patient-derived breast cancer cells.

    Published in:
    Cancer Immunology, Immunotherapy, 2019, v. 68, n. 1, p. 71, doi. 10.1007/s00262-018-2238-5
    By:
    • Tomasicchio, Michele;
    • Semple, Lynn;
    • Esmail, Aliasgar;
    • Meldau, Richard;
    • Randall, Philippa;
    • Pooran, Anil;
    • Davids, Malika;
    • Cairncross, Lydia;
    • Anderson, David;
    • Downs, Jennifer;
    • Malherbe, Francois;
    • Novitzky, Nicolas;
    • Panieri, Eugenio;
    • Oelofse, Suzette;
    • Londt, Rolanda;
    • Naiker, Thurandrie;
    • Dheda, Keertan
    Publication type:
    Article
    14
    15